Intra-arterial recombinant human tenecteplase tissue-type plasminogen activator (rhTNK-tPA)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Intra-arterial recombinant human tenecteplase tissue-type plasminogen activator (rhTNK-tPA), covering 2026-01-21 to 2026-01-21. Get the full timeline:
Most recent: Clinical Trial Update: Intra-arterial Recombinant Human Tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Medium Vessel Occlusion [Phase 2, Phase 3]